Guerbet SA (EPA:GBT)
France · Delayed Price · Currency is EUR 14.80
-0.08 (-0.54%)
Jan 12, 2026, 2:15 PM CET
Guerbet Market Cap
Guerbet has a market cap or net worth of €186.5 million as of January 12, 2026. Its market cap has decreased by -44.81% in one year.
Market Cap
186.50M
Enterprise Value
533.47M
Revenue
820.92M
Ranking
n/a
PE Ratio
24.10
Stock Price
€14.80
Market Cap Chart
Since March 3, 1992, Guerbet's market cap has increased from 142.85M to 186.50M, an increase of 30.56%. That is a compound annual growth rate of 0.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 186.50M | 3.50% |
| Dec 31, 2025 | 180.20M | -46.68% |
| Dec 31, 2024 | 337.92M | 37.29% |
| Dec 29, 2023 | 246.14M | 14.95% |
| Dec 30, 2022 | 214.13M | -54.42% |
| Dec 31, 2021 | 469.83M | 13.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 128.15B |
| Sanofi | 102.75B |
| Sartorius Stedim Biotech | 20.85B |
| bioMérieux | 13.33B |
| Eurofins Scientific SE | 12.24B |
| Ipsen | 10.46B |
| ABIVAX Société Anonyme | 7.71B |
| Virbac | 3.05B |